Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans to make an assessment of the effectiveness of the accelerated access pathway to enable access to new, innovative medicines.

As set out in the response to the Accelerated Access Review, published last year, the Accelerated Access Pathway is being developed and overseen by the newly formed Accelerated Access Collaborative (AAC) which brings together key leaders from the Government, the National Health Service, patient groups, and industry. The AAC will assess and review the effectiveness of the pathway, and provide an evaluation of its impact as part of regular reports to Ministers at the Department.